BioVersys AG

Industry · 10 registered clinical trials — 2 currently recruiting.

Status	Trial	Phase	Started
Not Yet Recruiting	Safety, Pharmacokinetics and Efficacy of BV100 Plus Low Dose Polymyxin B Plus Ceftazidime/Avibactam, or Plus C Ventilator Associated Bacterial Pneumonia (VABP), Hospital Acquired Bacterial Pneumonia (HABP), Blood Stream Infection	Phase 2	2026-07-01
Not Yet Recruiting	Phase 2a Trial of Alpibectir Plus Ethionamide for Tuberculosis Meningitis Tuberculosis Meningitis	Phase 2	2026-03-30
Completed	Study to Investigate the Penetration of Rifabutin Into the Lung After Multiple Intravenous Administrations of Bacterial Infections	Phase 1	2023-09-01
Completed	PK of BV100 in Patients VABP Suspected or Confirmed to Be Due to CRAB Ventilator Associated Pneumonia	Phase 2	2023-04-20
Completed	To Evaluate the Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of BV100 Bacterial Infections	Phase 1	2023-02-01
Completed	A Study to Assess the Phamacokinetics of BV100 in Participants with Varying Degrees of Hepatic Impairment Healthy Participants	Phase 1	2022-09-02
Completed	A Study to Assess Effect of BV100 on the Pharmacokinetics of Midazolam in Healthy Participants Healthy Volunteers	Phase 1	2022-09-01
Completed	Pharmacokinetics of Ethionamide and Ethionamide Sulfoxide in Patients Established on Treatment for Tuberculosi Tuberculosis, Pulmonary	—	2022-06-10
Completed	Pharmacokinetics and Safety of BV100 Administered as Single Intravenous Infusion to Subjects With Renal Impair Renal Impairment	Phase 1	2021-10-08
Completed	Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of BVL-GSK098 in Healthy Volunteer Healthy Volunteers	Phase 1	2020-12-02